Chemed CEO sells 2,000 shares in open-market trade

Chemed Corporation president and CEO Kevin J. McNamara reported an open-market sale of 2,000 shares of Chemed Capital Stock.

Rhea-AI Filing Summary

Chemed Corporation president and CEO Kevin J. McNamara reported an open-market sale of 2,000 shares of Chemed Capital Stock. The weighted average sale price was $421.13 per share, with individual trades executed between $418.99 and $424.95. Following this transaction, McNamara directly holds 90,219 shares of Chemed stock.

Insider Trade Summary

Net Seller: 2,000 shares

Net Sell 1 txn

Insider MCNAMARA KEVIN J

Role president and CEO

Sold 2,000 shs ($842K)

Type	Security	Shares	Price	Value
Sale	Capital Stock	2,000	$421.13	$842K

Holdings After Transaction: Capital Stock — 90,219 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $418.99 to $424.95. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

Key Figures

Shares sold: 2,000 shares Weighted average sale price: $421.13 per share Post-transaction holdings: 90,219 shares +2 more

5 metrics

Shares sold 2,000 shares Open-market sale of Chemed Capital Stock

Weighted average sale price $421.13 per share Average price for the 2,000 shares sold

Post-transaction holdings 90,219 shares Shares directly owned after the sale

Sale price range low $418.99 per share Lowest price among the multiple sale transactions

Sale price range high $424.95 per share Highest price among the multiple sale transactions

Key Terms

open-market sale, weighted average price, Capital Stock, beneficially owned

4 terms

open-market sale financial

"reported an open-market sale of 2,000 shares of Chemed Capital Stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Capital Stock financial

"security_title": "Capital Stock""

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

beneficially owned financial

"total_shares_following_transaction": "90219.0000""

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Chemed (CHE) CEO Kevin McNamara report?

Chemed CEO Kevin J. McNamara reported selling 2,000 shares of Chemed Capital Stock in open-market transactions. The trades occurred at a weighted average price of $421.13 per share, with a disclosed price range from $418.99 to $424.95.

At what price did Chemed (CHE) shares sell in Kevin McNamara’s Form 4 filing?

Kevin McNamara’s reported Chemed share sales had a weighted average price of $421.13 per share. According to the filing footnote, individual trades took place at prices ranging from $418.99 to $424.95 across multiple transactions.

How many Chemed (CHE) shares does Kevin McNamara hold after this Form 4 sale?

After selling 2,000 shares, Kevin McNamara directly holds 90,219 shares of Chemed Capital Stock. This post-transaction ownership figure is reported in the Form 4 as the total number of shares beneficially owned following the sale.

Was Kevin McNamara’s Chemed (CHE) share sale a single trade or multiple trades?

The Form 4 states the reported price is a weighted average, meaning the 2,000 shares were sold in multiple transactions. These trades occurred at various prices within a disclosed range from $418.99 to $424.95 per share.

What type of transaction is reported in Kevin McNamara’s Chemed (CHE) Form 4?

The filing describes the transaction as an open-market sale of non-derivative Capital Stock. It is coded as an “S” transaction, indicating a sale in the open market or a private transaction, and is reported as directly owned by Kevin McNamara.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 02:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCNAMARA KEVIN J

(Last) (First) (Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	president and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	05/01/2026		S		2,000	D	$421.13(1)	90,219	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $418.99 to $424.95. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

	Kevin J. McNamara	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)